Clinical trial

Kaletra: Therapy With Double Protease Inhibitors

NCT01075191

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2004-01-01

PhaseN/A

Study timeline

Study start (unknown)2004-01-01Date precision: month

Registry last updated2013-01-18

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Human Immunodeficiency Virusunresolved

Interventions

Sponsors & collaborators

AbbVie (prior sponsor, Abbott)lead sponsor

Mapped research locations

BerlinGermany5 FrankfurtGermany3 MünsterGermany2

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01075191 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.